Oncolytics Biotech, Inc (NASDAQ: ONCY) kicked off on Friday, up 14.86% from the previous trading day, before settling in for the closing price of $0.94. Over the past 52 weeks, ONCY has traded in a range of $0.33-$1.53.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 23.13% over the last five years. While this was happening, its average annual earnings per share was recorded 19.59%. With a float of $94.22 million, this company’s outstanding shares have now reached $97.41 million.
The firm has a total of 28 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Oncolytics Biotech, Inc (ONCY) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Oncolytics Biotech, Inc is 2.43%, while institutional ownership is 10.02%.
Oncolytics Biotech, Inc (ONCY) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -0.12 earnings per share (EPS), lower than consensus estimate (set at -0.11) by -0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.07 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 19.59% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 9.32% during the next five years compared to 23.13% growth over the previous five years of trading.
Oncolytics Biotech, Inc (NASDAQ: ONCY) Trading Performance Indicators
Take a look at Oncolytics Biotech, Inc’s (ONCY) current performance indicators. Last quarter, stock had a quick ratio of 2.88.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.27, a number that is poised to hit -0.06 in the next quarter and is forecasted to reach -0.25 in one year’s time.
Technical Analysis of Oncolytics Biotech, Inc (ONCY)
Analysing the last 5-days average volume posted by the [Oncolytics Biotech, Inc, ONCY], we can find that recorded value of 0.77 million was lower than the volume posted last year of 0.99 million. As of the previous 9 days, the stock’s Stochastic %D was 77.42%.
During the past 100 days, Oncolytics Biotech, Inc’s (ONCY) raw stochastic average was set at 73.64%, which indicates a significant decrease from 90.32% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1117 in the past 14 days, which was higher than the 0.0729 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.8996, while its 200-day Moving Average is $0.7765. Now, the first resistance to watch is $1.1333. This is followed by the second major resistance level at $1.1867. The third major resistance level sits at $1.2833. If the price goes on to break the first support level at $0.9833, it is likely to go to the next support level at $0.8867. Now, if the price goes above the second support level, the third support stands at $0.8333.
Oncolytics Biotech, Inc (NASDAQ: ONCY) Key Stats
The company with the Market Capitalisation of 104.33 million has total of 97,408K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -23,140 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -4,460 K.
